COVID 19 Vaccine List Worldwide: The World Health Organization (WHO) has validated various COVID-19 vaccines for emergency use listing, assessing factors such as quality, safety, efficacy, and potential side effects. As the global COVID-19 pandemic continues, vaccination is essential as these vaccines provide strong protection against severe illness and related symptoms.
As of now, a total of 40 vaccines have been approved by various countries to combat the COVID-19 pandemic. This article presents the latest COVID 19 Vaccine List 2025. In India, two vaccines are currently being administered as part of the nationwide vaccination drive.
COVID 19 Vaccine List 2025 Worldwide
This list includes the names of COVID-19 vaccines, their types, primary developers, and countries of origin.
- Zifivax
- Noora vaccine
- Covaxin
- Corbevax
- Convidecia
- Abdala
- KoviVac
- Gam-COVID-Vac
- Sputnik Light
- Sputnik V
- GEMCOVAC-19
- Turkovac
- Soberana 02
- Soberana Plus
- Ad26.COV2.S
- Covifenz
- MVC-COV1901
- Spikevax
- Recombinant SARS-CoV-2 Vaccine (CHO Cell)
- Nuvaxovid
- FAKHRAVAC (MIVAC)
- Vaxzevria
- Comirnaty
- Razi Cov Pars
- QazVac
- Covishield (Oxford/AstraZeneca formulation)
- COVOVAX (Novavax formulation)
- KCONVAC
- COVIran Barekat
- Covilo
- Inactivated (Vero Cells)
- CoronaVac
- SKYCovione
- TAK-019 (Novavax formulation)
- TAK-919 (Moderna formulation)
- VLA2001
- SpikoGen
- Aurora-CoV
- EpiVacCorona
- ZyCoV-D
| Name | Vaccine Type | Primary Developers | Country of Origin |
|---|---|---|---|
| Comirnaty (BNT162b2) | mRNA-based vaccine | Pfizer, BioNTech, Fosun Pharma | Multinational |
| Moderna Covid-19 Vaccine (mRNA-1273) | mRNA-based vaccine | Moderna, BARDA, NIAID | US |
| COVID-19 Vaccine AstraZeneca (AZD1222); also known as Vaxzevria and Covishield | Adenovirus vaccine | BARDA, OWS | UK |
| Sputnik V | Recombinant adenovirus vaccine (rAd26 and rAd5) | Gamaleya Research Institute, Acellena Contract Drug Research and Development | Russia |
| COVID-19 Vaccine Janssen (JNJ-78436735; Ad26.COV2.S) | Non-replicating viral vector | Janssen Vaccines (Johnson & Johnson) | The Netherlands, US |
| CoronaVac | Inactivated vaccine (formalin with alum adjuvant) | Sinovac | China |
| BBIBP-CorV | Inactivated vaccine | Beijing Institute of Biological Products; China National Pharmaceutical Group (Sinopharm) | China |
| EpiVacCorona | Peptide vaccine | Federal Budgetary Research Institution State Research Center of Virology and Biotechnology | Russia |
| Covaxin (BBV152) | Inactivated vaccine | Bharat Biotech, ICMR; Ocugen | India |
| CoviVac | Inactivated vaccine | Chumakov Federal Scientific Center for Research and Development of Immune and Biological Products | Russia |
| ZF2001 | Recombinant vaccine | Anhui Zhifei Longcom Biopharmaceutical, Institute of Microbiology of the Chinese Academy of Sciences | China, Uzbekistan |
| QazVac (QazCovid-in) | Inactivated vaccine | Research Institute for Biological Safety Problems | Kazakhstan |
Countries have commenced the rollout of these COVID-19 vaccines for their populations, aiming to curb the spread of the virus and reduce cases and mortality rates.
WHO Emergency Use Listing
The WHO Emergency Use Listing allows for the distribution of unlicensed vaccines during public health emergencies. Below are some criteria for this listing:
- Identification of serious diseases that can cause outbreaks.
- Demonstrated ineffectiveness of existing medicines or vaccines.
- Compliance with Good Manufacturing Practices (GMP).
Read: COVID Medicine List for Treatment
In India, the Covaxin and Covishield vaccines are available for citizens free of charge at various vaccination centers. The Sputnik V vaccine is also in use at select locations. Other vaccines are undergoing trials, and updates regarding their availability will be provided soon.
WHO Approved COVID 19 Vaccine List
Access to safe and effective vaccines is critical for ending the COVID-19 pandemic. The WHO remains dedicated to collaborating with partners to develop and deploy these vaccines. However, vigilance is necessary; vaccines do not negate the need for preventive measures such as masks, hand hygiene, and social distancing.
Vaccination protects against severe diseases but should be accompanied by continued precautionary measures to safeguard overall public health. For regular updates on vaccine developments, refer to the WHO’s landscape of COVID-19 vaccine candidates.
Side Effects of COVID 19 Vaccine
Vaccines are generally safe. Mild side effects may occur as signs of the body building protection against COVID-19. Below are common side effects that may occur:
Common Side Effects of COVID-19 Vaccines
Side effects typically include pain at the injection site, fatigue, headache, muscle pain, chills, and diarrhea. The severity of side effects may vary by vaccine. Ongoing monitoring ensures safety across vaccination programs.
Visit the WHO COVID-19 Vaccines page for continuous updates: WHO COVID-19 Vaccines.
Also Read: COVID 19 Vaccine Hospitals List
